heart icon heart icon
Our Stories
Our Company
Follow Us
Explore more Johnson & Johnson sites:
Australia
Argentina
Brazil
Canada
Chile
China
Colombia
Costa Rica
Czech Republic
Ecuador
Germany
India
Japan
Mexico
New Zealand / Pacific
Paraguay
Peru
Philippines
Russia
Switzerland
German
English
French
Italian
United States
Uruguay
Venezuela
Share

Media Center

Read the Story
Re-Ignite: The Johnson & Johnson Career Program That's Helping People Return to the World of STEM
Re-Ignite: The Johnson & Johnson Career Program That's Helping People Return to the World of STEM
“They Needed to Feel Loved”: How One Nurse Revolutionized Patient Care During the AIDS Crisis
365 Days of Caring: 13 Ways Johnson & Johnson Helped Progress Health for Humanity in 2018
5 Important Facts About the Safety of Talc

Latest Press Releases

Innovation
June 14, 2019
Janssen reports top-line Phase 3 results for TREMFYA® (guselkumab) in adults with active psoriatic arthritis
Innovation
June 11, 2019
INVOKANA® (canagliflozin) Significantly Reduced Major Cardiovascular Events and Kidney Failure in Patients with Type 2 Diabetes and Chronic Kidney Disease in New CREDENCE Analysis
Our Company
June 05, 2019
Johnson & Johnson Releases 2018 Health for Humanity Report
Innovation
June 03, 2019
IMBRUVICA® (ibrutinib) Long-Term Data from Two Pivotal Phase 3 Studies at ASCO and EHA Demonstrate Sustained Efficacy and Safety in Patients with Chronic Lymphocytic Leukemia (CLL)
Innovation
June 03, 2019
DARZALEX® (daratumumab) Investigational Study Shows Increased Depth of Response and Longer Progression-Free Survival in Patients with Newly Diagnosed Multiple Myeloma Who are Eligible for a Transplant
Innovation
June 03, 2019
Phase 3 COLUMBA Study Investigating a Subcutaneous Formulation of DARZALEX® (daratumumab) Showed Non-Inferiority to Intravenous Administration in Patients with Relapsed/Refractory Multiple Myeloma
See All Press Releases

Photos, Videos, Infographics & More

See All

J&J Fast Facts

Our Company
We Work All Over the World
We Work All Over the World
We have over 134,000 employees working across more than 260 operating companies located in 60 countries around the world.
Get to know Johnson & Johnson
See All Fast Facts

Social Media

  • On #WorldRefugeeDay, explore our interactive map to see how #JNJ supports refugees around the world through program… https://t.co/bcbfagftLy
    JNJNews
  • Ahead of his #AspenIdeasHealth speech, Michael Sneed, EVP, Global Corporate Affairs & Chief Communication Officer,… https://t.co/d6rx9oqk7C
    JNJNews
  • President of @JanssenGlobal France, @Emma__QUILES, reflects on the power of science and technology, and how open in… https://t.co/k5pGLWGHsR
    JNJNews
Follow Us On Twitter

More From Johnson & Johnson

This site uses cookies as described in our Cookie Policy. Please click the "Accept" button or continue to use our site if you agree to our use of cookies.
You are now leaving jnj.com. The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.
Continue